Lamictal vs Symbicort: side-by-side comparison
Lamictal (Neurological Medications) and Symbicort (Respiratory Medications) belong to different therapeutic classes and are rarely interchangeable. This page compares the medications' purposes, mechanisms and the situations where each is used.
| Property | Lamictal | Symbicort |
|---|---|---|
| Active ingredient | Lamotrigine | Budesonide, Formoterol |
| Manufacturer | GlaxoSmithKline | AstraZeneca |
| Class | Neurological Medications | Respiratory Medications |
| Strengths | 25mg, 50mg, 100mg, 200mg | 80/4.5 mcg, 160/4.5 mcg, 200/6 mcg, 400/12 mcg |
| Forms | tablet, chewable tablet, orally disintegrating tablet, extended-release tablet | dry powder inhaler, metered-dose inhaler |
What's the same
Lamictal and Symbicort are used in very different patients, and the points in common are limited. The main shared element is that both meet regulatory standards for efficacy and safety and benefit from pharmacist oversight.
Key differences
Lamictal belongs to Neurological Medications while Symbicort belongs to Respiratory Medications. Indications, mechanisms and target populations differ. The comparison is most useful when a clinician has mentioned both medications and the patient wants to understand where each fits.
Mechanism and action
Lamictal: Lamotrigine selectively blocks voltage-gated sodium channels, stabilising neuronal membranes and reducing the release of excitatory neurotransmitters, particularly glutamate. Symbicort: Budesonide reduces chronic airway inflammation through glucocorticoid receptor activation, decreasing inflammatory cell recruitment and cytokine release.
When Lamictal is preferred
Lamictal is approved in adults and children aged 2 years and older as adjunctive or monotherapy for partial-onset seizures, primary generalised tonic-clonic seizures and seizures associated with Lennox-Gastaut syndrome.
When Symbicort is preferred
Symbicort is approved in adults and adolescents from age 12 (younger in some markets) for the regular treatment of asthma when combination therapy of a long-acting beta-2 agonist and an inhaled corticosteroid is appropriate, and in some markets for symptom relief in COPD.
Frequently asked questions
Is Lamictal or Symbicort better? ▾
Lamictal and Symbicort are not interchangeable — they treat different conditions. Asking which is "better" is meaningful only when a clinician has weighed both for the same specific clinical scenario.
Can I switch from Lamictal to Symbicort? ▾
Switching between Lamictal and Symbicort is rarely an appropriate decision since they belong to different classes and treat different conditions. The real question is usually whether the diagnosis calls for one medication or the other — which the prescriber resolves.
Do Lamictal and Symbicort have the same side effects? ▾
No — they belong to different classes and have distinct side-effect profiles. Each medication has its own prescribing information.
More Lamictal comparisons
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.